This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (71)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Liver/ Biliary Tract/ Pancreatic Diseases  • Surgical Oncology  • Alert me on articles by topic

Jason Suits, BS; Richard Frazee, MD; Richard A. Erickson, MD

Arch Surg. 1999;134:639-643.

Hypothesis:  Endoscopic ultrasound (EUS) and endoscopic ultrasound–guided fine needle aspiration (EUS-FNA) are accurate for the preoperative staging of pancreatic ductal carcinoma.

Design  Retrospective medical record review.

Patients  A prospective registry of 98 patients having EUS-FNA for peripancreatic masses from April 1994 to April 1998 was analyzed.

Main Outcome Measure  The accuracy of EUS-FNA for preoperative diagnosis and staging of peripancreatic neoplasms.

Results  Ninety-eight patients, aged 41 to 91 years (mean age, 67 years) with peripancreatic masses were evaluated by EUS-FNA. All patients had initial computed tomography scanning with a mass seen in 49 patients, "fullness" to the pancreas in 28 patients, and no mass seen in 21 patients. Evaluation with EUS-FNA revealed 22 benign lesions, 18 T2 masses, 37 T3 masses, 1 T4 mass, and 20 masses representing nonpancreatic tumors. Results of EUS-FNA of adjacent lymph nodes were positive in 27 patients. Twenty-seven patients had surgical resection or palliation permitting operative and pathologic staging. On comparison of EUS-FNA staging with surgical staging, 12 patients were the same stage, 14 patients were upstaged, and 1 patient was downstaged. The remaining patients who did not have surgery have been followed up for a mean of 15 months. Overall accuracy of EUS-FNA for differentiating benign from malignant masses was 96%.

Conclusions  Endoscopic ultrasound–guided fine needle aspiration is a useful technique for the evaluation of pancreatic masses. It is highly accurate for differentiating between benign and malignant lesions and for predicting T stage, but is limited for predicting nodal status.

From the Departments of Surgery (Mr Suits and Dr Frazee) and Medicine (Dr Erickson), Scott & White Clinic and Memorial Hospital, Scott, Sherwood and Brindley Foundation, Texas A&M University Health Science Center, College of Medicine, Temple.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

My approach to pancreatic fine needle aspiration
Leiman
J. Clin. Pathol. 2007;60:43-49.
ABSTRACT | FULL TEXT  

Low Sensitivity of the ki-ras Polymerase Chain Reaction for Diagnosing Pancreatic Cancer From Pancreatic Juice and Bile: A Multicenter Prospective Trial
Trumper et al.
JCO 2002;20:4331-4337.
ABSTRACT | FULL TEXT